bronchoscope News
-
Noah Medical Presents Data, Showcases the Galaxy System at CHEST Annual Meeting
Medical robotics innovator Noah Medical provided physicians attending the American College of Chest Physicians 2022 meeting with a preview of study data documenting its high tool in lesion rate. This data subset and demonstrations of the Galaxy System were met with excellent reviews from the interventional pulmonology community. The Galaxy System is designed to provide a fully integrated ...
By Noah Medical
-
Edison Shines Light on the Monarch Platform
Innovation begins when there is a need for something better. The Monarch™ Platform has been named a 2019 Edison Award finalist in the medical/dental category. The annual award competition honors excellence in new product and service development, marketing, human-centered design and innovation. Since its inception in 1987, the Edison Awards have sought to foster innovation by recognizing ...
-
Noah Medical to Showcase the Galaxy System at AABIP Annual Meeting
Medical robotics innovator Noah Medical today revealed that the second public demonstration of its groundbreaking Galaxy System will take place from August 11th - 13th at the American Association for Bronchology and Interventional Pulmonology (AABIP) annual meeting in Nashville, TN. The Galaxy System is the only fully integrated solution for navigated bronchoscopy, designed to dramatically ...
By Noah Medical
-
Preventing New Cases of Legionnaires’ Disease in Health Care Environments
One in four people that contract Legionnaires’ disease from a health care facility dies according to the Centers for Disease Control and Prevention (CDC). These unsettling figures were posted in June issue of the CDC’s Vitalsigns™ publication. The focus of the document was to raise awareness of the problem of patients contracting Legionnaires’ disease in health care ...
-
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the Zephyr® Endobronchial Valve for treating severe COPD/emphysema patients following a positive recommendation by Pharmaceuticals and Medical Devices Agency (PMDA). ...
-
CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at the 2022 European Respiratory Society (ERS) International Conference. Data on the first 40 patients in the study demonstrated that treatment with the AeriSeal System successfully converted the ...
-
Biostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the Bronchus
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted at the Mayo Clinic and published last August) and FDA approval to commence a clinical trial of the Biostage Esophageal Implant for severe esophageal disease including cancer, today announced that the U.S. Patent and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you